TABLE 2 .
Bacterial strains used in this study
| Strain | Description | Source or reference(s) |
|---|---|---|
| NZ131 | Wild-type M49 S. pyogenes isolate | 48, 53 |
| JCC131 | NZ131 Δrgg3::cat; Cmr | 26 |
| BNL158 | NZ131 with integrated p7INT; Ermr | 54 |
| BNL170 | NZ131 shp2GGG shp3GGG; unmarked | This study |
| BNL177 | NZ131 shp2GGG shp3GGG with integrated pBL111; Ermr | This study |
| A909 | Wild-type S. agalactiae type Ia/C clinical isolate | 49, 55 |
| BLC100 | A909 ΔrovS; unmarked | This study |
| BLC101 | A909 shp1520GGG; unmarked | This study |
| BLC102 | A909 ΔrovS shp1520GGG; unmarked | This study |
| BLC103 | A909 with mutated putative RovS binding site; unmarked | This study |
| GGS-LT1 | S. dysgalactiae subsp. equisimilis strain isolated in Lin Tao laboratory and identified by 16S rRNA sequencing | This study |